• Direction
    Leading Science, Saving Lives — 5-year Strategic Plan to further enhance the impact of the Canadian Critical Care Trials Group in Canada & around the world.
  • Excellence
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Research
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • National
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Commitment
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous & ethical manner, and communicated in a timely & effective way.
  • Focus on
    January Meeting: 25th CCCTG Anniversary celebrations

    Dear members & invited guests: join us for some 25th CCCTG Anniversary celebrations throughout the upcoming January meeting. The 25th Anniversary Committee is planning some games (prizes), reflections (including by our founders), toasts (and roasts) in the spirit of honouring the CCCTG history.

  • Focus on
    Nicolay Ferrari as Executive Director of the CCCTG

    The CCCTG is happy to announce that a new member has joined our team! Nicolay Ferrari has accepted the position of Executive Director and will be working closely with the membership to help implement our strategic plan.

  • Focus on
    The OVATION study funded by CIHR and FRQS

    Fran├žois Lamontagne and the OVATION team have received funding for this important multicenter clinical trial and parallel prospective observational study of blood pressure targets for vasopressors.

  • Focus on
    Severe Respiratory Illness Outbreaks in China and the Middle East: Increasing number of cases of Avian-Origin Influenza A (H7N9) in China

    The preliminary case studies have been reported and characterize patients of ages range from 4 to 87 years,  a presentation with fever, cough and dyspnea, evolving severe hypoxic respiratory illness and ARDS within approximately 7 days of the onset of symptoms. Read more...

  • Focus on
    OSCILLATE in the New England Journal of Medicine

    OSCILLATE trial shows High PEEP, Low Tidal Volume conventional ventilation as or more effective than High Frequency Oscillation - results published in the New England Journal of Medicine - www.nejm.org.

  • Focus on
    TBI-Prognosis study funded by CIHR

    Alexis Turgeon and the TBI-Prognosis team recently received funding for this multicenter prospective study aiming to develop a prognostic model and prediction rule following severe traumatic brain injury. The TBI-Prognosis Study involves researchers and trauma centers from across Canada.

  • Michelle Kho

    Dr. Michelle Kho receives a Canada Research Chair!

  • Jacques Lacroix

    Jacques Lacroix, member of the CCCTG, is the recipient of the prestigious Alan Ross Award.

  • 2014 MEETING

    The CCCTG Winter 2014 Scientific Meeting will be held at the Post Hotel, in Lake Louise, Alberta, on January 27 to 30. More than 100 members attended the last winter meeting.

  • Fall Meeting

    Wednesday November 13, 2013 from 1:00 to 5:00 pm & Thursday November 14 All-Day. University of Toronto Faculty Club.

  • CCCTG Fall 2013 Meeting

    Sheraton Hotel (Tuesday November 12) and Sunnybrook Vaughan Estates (Wednesday November 13, 2013)